Okyo Pharma Limited NPV (OKYO) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Nov 2024 12:00 PM
GNW
OKYO Pharma to Participate at the 4th Annual ...
30 Oct 2024 11:00 AM
GNW
OKYO Pharma to Present at International Tear ...
23 Oct 2024 12:00 PM
GNW
OKYO Pharma Announces First Patient Dosed in ...
16 Oct 2024 12:00 PM
GNW
OKYO Pharma Announces Start of Phase 2 Clinic...
10 Sep 2024 12:00 PM
GNW
OKYO Pharma Announces Chairman Acquires Share...
05 Sep 2024 12:00 PM
GNW
OKYO Pharma Announces Chairman Acquires Share...
27 Aug 2024 12:00 PM
GNW
OKYO Pharma Granted U.S. Patent Covering OK-1...
23 Aug 2024 02:00 PM
GNW
OKYO Pharma CEO Interview to Air on Bloomberg...
23 Aug 2024 12:00 PM
GNW
OKYO Pharma Announces Chairman Acquires Share...
21 Aug 2024 12:00 PM
GNW
OKYO Pharma Announces Chairman Acquires Share...
15 Aug 2024 05:13 PM
GNW
OKYO Pharma Participates in H.C. Wainwright 4...
06 Aug 2024 12:00 PM
GNW
OKYO Pharma Granted European Patent Covering ...
11 Jul 2024 12:00 PM
GNW
OKYO Pharma to Initiate Neuropathic Corneal P...
10 Jul 2024 12:00 PM
GNW
OKYO Pharma Announces Promising Categorical D...
08 May 2024 12:00 PM
GNW
OKYO Pharma Announces Participation in May 20...
30 Apr 2024 12:00 PM
GNW
OKYO Pharma Announces Upcoming Presentation o...
09 Apr 2024 12:00 AM
GNW
OKYO Pharma to Reschedule Key Opinion Leader ...
02 Apr 2024 12:00 PM
GNW
OKYO Pharma Announces Upcoming Presentation o...
22 Mar 2024 11:00 AM
GNW
OKYO Pharma Announces OK-101 Successfully Ach...
21 Mar 2024 11:00 AM
GNW
OKYO Pharma to Host Key Opinion Leader Event ...
20 Mar 2024 11:00 AM
GNW
OKYO Pharma to Release New and Comprehensive ...
09 Feb 2024 12:00 PM
GNW
OKYO Pharma Receives FDA Approval of IND for ...
31 Jan 2024 12:00 PM
GNW
OKYO Pharma Announces Distinguished Ophthalmo...
08 Jan 2024 12:00 PM
GNW
OKYO Pharma Announces OK-101 Successfully Ach...
05 Jan 2024 02:30 PM
GNW
OKYO Pharma to Present at the Biotech Showcas...
04 Dec 2023 12:00 PM
GNW
OKYO Pharma Announces Last Patient Enrolled i...
31 Oct 2023 11:00 AM
GNW
OKYO Pharma Announces $5.84 Million Cash Rais...
09 Oct 2023 12:00 PM
GNW
OKYO Pharma Announces Filing of an Investigat...
05 Oct 2023 12:00 PM
GNW
OKYO Pharma Announces Positive Safety Data Pr...
15 Sep 2023 12:00 PM
GNW
OKYO Pharma Announces Closing of $4.0 Million...
14 Sep 2023 02:15 PM
GNW
OKYO Pharma Announces Pricing of $4.0 Million...
14 Sep 2023 01:45 PM
GNW
OKYO Pharma Limited Announces Withdrawal of P...
13 Sep 2023 09:05 PM
GNW
OKYO Pharma Announces Public Offering of Ordi...
08 Sep 2023 12:00 PM
GNW
OKYO Pharma Completes Enrollment in Phase 2 C...
30 Aug 2023 12:00 PM
GNW
OKYO Pharma Achieves 90% Enrollment in 240-Pa...
29 Aug 2023 12:00 PM
GNW
OKYO Pharma Limited Regains Compliance with N...
15 Aug 2023 02:00 PM
GNW
OKYO Pharma Limited Reports Annual Results fo...
31 Jul 2023 07:18 AM
GNW
OKYO Pharma Limited Announces Withdrawal of P...
28 Jul 2023 10:25 PM
GNW
OKYO Pharma Announces Proposed Public Offerin...
28 Jul 2023 12:01 PM
GNW
OKYO Pharma Plans to Initiate Phase 2 Trial o...
27 Jul 2023 04:30 PM
GNW
OKYO Pharma Announces Appointment of William ...
06 Jun 2023 02:30 PM
GNW
OKYO Pharma Announces Randomized Segment Now ...
22 May 2023 08:15 AM
RNS
London Stock Exchange Delisting
19 May 2023 08:00 AM
RNS
ADS Program collapse
15 May 2023 07:00 AM
RNS
Change of Record Time and Last Day of Dealings
11 May 2023 12:00 PM
RNS
Webull Corporate Communications Service Platform
11 May 2023 07:00 AM
RNS
Change of Delisting Date to 22 May 2023
03 May 2023 01:00 PM
RNS
Result of Meeting
03 May 2023 07:00 AM
RNS
Presentation on OK-101 at ASCRS
02 May 2023 07:00 AM
RNS
First-Patient First-Visit for Phase 2 Trial
UK 100

Latest directors dealings